| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOMATERIALS.2009.10.044 |
| P698 | PubMed publication ID | 19883938 |
| P2093 | author name string | Yanyan Jiang | |
| Saijie Zhu | |||
| Yuanying Pei | |||
| Guotao Tang | |||
| Lili Qian | |||
| Jiayuan Lin | |||
| Minghuang Hong | |||
| P433 | issue | 6 | |
| P921 | main subject | doxorubicin | Q18936 |
| P304 | page(s) | 1360-1371 | |
| P577 | publication date | 2009-11-02 | |
| P1433 | published in | Biomaterials | Q15751139 |
| P1476 | title | Partly PEGylated polyamidoamine dendrimer for tumor-selective targeting of doxorubicin: the effects of PEGylation degree and drug conjugation style | |
| P478 | volume | 31 |
| Q36327549 | A pH-responsive prodrug delivery system of 10-HCPT for controlled release and tumor targeting |
| Q38074172 | Acid-degradable polymers for drug delivery: a decade of innovation. |
| Q41942709 | Antimicrobial activity of CdS and Ag2S quantum dots immobilized on poly(amidoamine) grafted carbon nanotubes |
| Q33734954 | Charge-reversal polyamidoamine dendrimer for cascade nuclear drug delivery. |
| Q34445374 | Comparative studies of polyethylenimine-doxorubicin conjugates with pH-sensitive and pH-insensitive linkers. |
| Q45035342 | Conjugation to Poly(amidoamine) Dendrimers and Pulmonary Delivery Reduce Cardiac Accumulation and Enhance Antitumor Activity of Doxorubicin in Lung Metastasis. |
| Q31122095 | Cytotoxicity and biodistribution studies on PEGylated EDA and PEG cored PAMAM dendrimers |
| Q26828423 | Dendrimer advances for the central nervous system delivery of therapeutics |
| Q35150539 | Dendrimer nanocarriers for transport modulation across models of the pulmonary epithelium |
| Q36690711 | Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry |
| Q37886750 | Dendrimers and miktoarm polymers based multivalent nanocarriers for efficient and targeted drug delivery. |
| Q57556323 | Dendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful Nanomedicine |
| Q37408047 | Deposition of doxorubicin in rats following administration of three newly synthesized doxorubicin conjugates |
| Q57341091 | Design of Stimuli-Responsive Dendrimers for Biomedical Purposes |
| Q37823446 | Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations |
| Q39629413 | Development and in vitro characterization of paclitaxel and docetaxel loaded into hydrophobically derivatized hyperbranched polyglycerols |
| Q39011604 | Development of biodegradable polymeric implants of RGD-modified PEG-PAMAM-DOX conjugates for long-term intratumoral release |
| Q35967474 | Development of individualized anti-metastasis strategies by engineering nanomedicines |
| Q30421664 | Development of nanoscale approaches for ovarian cancer therapeutics and diagnostics |
| Q58716768 | Doxorubicin-Conjugated PAMAM Dendrimers for pH-Responsive Drug Release and Folic Acid-Targeted Cancer Therapy |
| Q39264651 | Effect of cationic side-chains on intracellular delivery and cytotoxicity of pH sensitive polymer-doxorubicin nanocarriers |
| Q33792946 | Effect of the Route of Administration and PEGylation of Poly(amidoamine) Dendrimers on Their Systemic and Lung Cellular Biodistribution |
| Q38990966 | EphA2 targeting pegylated nanocarrier drug delivery system for treatment of lung cancer |
| Q84580486 | Erratum to: PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation |
| Q47263594 | Evolution and Clinical Translation of Drug Delivery Nanomaterials |
| Q38142889 | Functional magnetic nanoparticles for non-viral gene delivery and MR imaging. |
| Q38973975 | Hydrophobic cavity formed by oligopeptide for doxorubicin delivery based on dendritic poly(L-lysine). |
| Q28483980 | In vitro and in vivo antitumor activity of a novel pH-activated polymeric drug delivery system for doxorubicin |
| Q64244720 | Low Molecular Weight Heparin-Coated and Dendrimer-Based Core-Shell Nanoplatform with Enhanced Immune Activation and Multiple Anti-Metastatic Effects for Melanoma Treatment |
| Q48658092 | Maximized nanodrug-loaded mesenchymal stem cells by a dual drug-loaded mode for the systemic treatment of metastatic lung cancer |
| Q37955127 | Microfabricated particulate drug-delivery systems |
| Q38962983 | Molecularly precise dendrimer-drug conjugates with tunable drug release for cancer therapy. |
| Q35108257 | Multifunctional drug nanocarriers formed by cRGD-conjugated βCD-PAMAM-PEG for targeted cancer therapy |
| Q57344629 | PEG-b-PtBA-b-PHEMA well-defined amphiphilic triblock copolymer: Synthesis, self-assembly, and application in drug delivery |
| Q39646320 | PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors |
| Q92495277 | Partial Surface Modification of Low Generation Polyamidoamine Dendrimers: Gaining Insight into their Potential for Improved Carboplatin Delivery |
| Q38736230 | Partially PEGylated PAMAM dendrimers as solubility enhancers of Silybin. |
| Q39007103 | Peptide dendrimer-Doxorubicin conjugate-based nanoparticles as an enzyme-responsive drug delivery system for cancer therapy |
| Q36562350 | Peptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatment |
| Q30664584 | Poly(ethylene oxide)-block-polyphosphoester-graft-paclitaxel conjugates with acid-labile linkages as a pH-sensitive and functional nanoscopic platform for paclitaxel delivery |
| Q90439921 | Polymer-drug conjugate therapeutics: advances, insights and prospects |
| Q38932548 | Polypeptide-based Micelles for Delivery of Irinotecan: Physicochemical and In vivo Characterization |
| Q38509638 | Preclinical studies of dendrimer prodrugs |
| Q51571874 | Preparation of pyrenyl-based multifunctional nanocomposites for biomedical applications. |
| Q50957929 | Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer. |
| Q39584202 | RGD-modified PEG-PAMAM-DOX conjugate: in vitro and in vivo targeting to both tumor neovascular endothelial cells and tumor cells |
| Q38074441 | Reversibly crosslinked nanocarriers for on-demand drug delivery in cancer treatment |
| Q34987929 | Stimuli Sensitive Amphiphilic Dendrimers |
| Q38993179 | Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer |
| Q39389155 | Synthesis and characterization of G5 PAMAM dendrimer containing daunorubicin for targeting cancer cells |
| Q35971215 | Synthesis and in vitro evaluation of pH-sensitive PEG-I-dC16 block polymer micelles for anticancer drug delivery |
| Q38753654 | Synthesis of a novel PEGDGA-coated hPAMAM complex as an efficient and biocompatible gene delivery vector: an in vitro and in vivo study |
| Q35234716 | Targeted delivery of doxorubicin-utilizing chitosan nanoparticles surface-functionalized with anti-Her2 trastuzumab |
| Q58587671 | Targeting Groups Employed in Selective Dendrons and Dendrimers |
| Q37624646 | Targeting of tumor-associated macrophages made possible by PEG-sheddable, mannose-modified nanoparticles |
| Q36553206 | The effect of the acid-sensitivity of 4-(N)-stearoyl gemcitabine-loaded micelles on drug resistance caused by RRM1 overexpression. |
| Q37938830 | Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. |
| Q33769951 | Theranostic tumor homing nanocarriers for the treatment of lung cancer |
| Q36774169 | Trastuzumab-grafted PAMAM dendrimers for the selective delivery of anticancer drugs to HER2-positive breast cancer |
| Q50504656 | Tunable pH-sensitive poly(β-amino ester)s synthesized from primary amines and diacrylates for intracellular drug delivery. |
| Q36823809 | Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier |
| Q56225480 | pH-Responsive polymers |
| Q38168593 | pH-sensitive drug-delivery systems for tumor targeting |
Search more.